Cargando…

Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington’s Disease

Neuronal loss alongside altered energy metabolism, are key features of Huntington’s disease (HD) pathology. The orexigenic gut-peptide hormone ghrelin is known to stimulate appetite and affect whole body energy metabolism. Liraglutide is an efficient anti-type 2 diabetes incretin drug, with neuropro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duarte, Ana I., Sjögren, Marie, Santos, Maria S., Oliveira, Catarina R., Moreira, Paula I., Björkqvist, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997749/ https://www.ncbi.nlm.nih.gov/pubmed/29895889 http://dx.doi.org/10.1038/s41598-018-27121-w

Ejemplares similares

Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington’s disease
por: Sjögren, Marie, et al.
Publicado: (2017)

Centrally and peripherally altered glucose transporters: is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?
por: Björkqvist, Maria
Publicado: (2023)

Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
por: Stan, Tiberiu Loredan, et al.
Publicado: (2020)

Abnormal peripheral chemokine profile in Huntington’s disease
por: Wild, Edward, et al.
Publicado: (2011)

Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
por: Henningsen, Jo B., et al.
Publicado: (2021)

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington’s disease R6/2 mice
por: Soylu-Kucharz, Rana, et al.
Publicado: (2017)

White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington’s Disease
por: McCourt, Andrew C., et al.
Publicado: (2016)

Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
por: Dickson, Elna, et al.
Publicado: (2022)

Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
por: Petersén, Åsa, et al.
Publicado: (2005)

Insulin in Central Nervous System: More than Just a Peripheral Hormone
por: Duarte, Ana I., et al.
Publicado: (2012)

A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward
por: Silajdžić, Edina, et al.
Publicado: (2018)

Liraglutide Protects Against Brain Amyloid-β(1–42) Accumulation in Female Mice with Early Alzheimer’s Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation
por: Duarte, Ana I., et al.
Publicado: (2020)

Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
por: Dickson, Elna, et al.
Publicado: (2022)

JAK/STAT Signalling in Huntington’s Disease Immune Cells
por: Träger, Ulrike, et al.
Publicado: (2013)

Liraglutide Improves Cognitive and Neuronal Function in 3-NP Rat Model of Huntington’s Disease
por: Shawki, Samar M., et al.
Publicado: (2021)

Ghrelin O-Acyl Transferase: Bridging Ghrelin and Energy Homeostasis
por: Shlimun, Andrew, et al.
Publicado: (2011)

Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models
por: Träger, Ulrike, et al.
Publicado: (2015)

Ghrelin Receptor Influence on Cocaine Reward is Not Directly Dependent on Peripheral Acyl-Ghrelin
por: Wenthur, Cody J., et al.
Publicado: (2019)

The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington's disease mice
por: Pinho, Brígida R., et al.
Publicado: (2020)

Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism
por: Lim, Chung Thong, et al.
Publicado: (2013)

A Metabolic Study of Huntington’s Disease
por: Nambron, Rajasree, et al.
Publicado: (2016)

Ghrelin: Central and Peripheral Implications in Anorexia Nervosa
por: Méquinion, Mathieu, et al.
Publicado: (2013)

Effect of unacylated ghrelin on peripheral nerve regeneration
por: Ronchi, Giulia, et al.
Publicado: (2021)

Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease
por: Verma, Subodh, et al.
Publicado: (2022)

Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington´s disease
por: Nguyen, Huu Phuc, et al.
Publicado: (2010)

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
por: Morena, Emanuele, et al.
Publicado: (2023)

Ghrelin and the Control of Energy Balance in Females
por: Smith, Andrea, et al.
Publicado: (2022)

Liraglutide Suppresses the Plasma Levels of Active and Des-Acyl Ghrelin Independently of Active Glucagon-Like Peptide-1 Levels in Mice
por: Nonogaki, Katsunori, et al.
Publicado: (2013)

Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease – How Anti-Diabetics Could be a Solution for Dementia
por: Sebastião, Inês, et al.
Publicado: (2014)

In Situ Localization and Rhythmic Expression of Ghrelin and ghs-r1 Ghrelin Receptor in the Brain and Gastrointestinal Tract of Goldfish (Carassius auratus)
por: Sánchez-Bretaño, Aída, et al.
Publicado: (2015)

Impaired Nitric Oxide Mediated Vasodilation In The Peripheral Circulation In The R6/2 Mouse Model Of Huntington’s Disease
por: Kane, Andrew D., et al.
Publicado: (2016)

A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease
por: Kalliolia, Eirini, et al.
Publicado: (2015)

Ghrelin and the central regulation of feeding and energy balance
por: Abizaid, Alfonso, et al.
Publicado: (2012)

Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's Disease
por: McCourt, Andrew C, et al.
Publicado: (2015)

Altered Aconitase 2 Activity in Huntington’s Disease Peripheral Blood Cells and Mouse Model Striatum
por: Chen, Chiung-Mei, et al.
Publicado: (2017)

Ghrelin inhibits LPS-induced release of IL-6 from mouse dopaminergic neurones
por: Beynon, Amy L, et al.
Publicado: (2013)

Preprandial ghrelin is not affected by macronutrient intake, energy intake or energy expenditure
por: Paul, David R, et al.
Publicado: (2005)

Ghrelin
por: Müller, T.D., et al.
Publicado: (2015)

Dual peripheral model up to Serpukhov energies
por: Schrempp, Barbara, et al.
Publicado: (1974)

Effect of Pioglitazone on Energy Intake and Ghrelin in Diabetic Patients
por: Martin, Corby K., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_20d1uf6dbumcsqc4mabk96vp04